The PGRN deficiency also exacerbates the hyperhomocysteinemia-induced left ventricular dilation and hypertrophy in a rodent models, suggesting that PGRN is one of the target molecules vital to maintain cardiovascular function [54]. This evidence concerns the gene GRN and hypertrophy.